Skip to main content
Top
Published in: BMC Nephrology 1/2019

Open Access 01-12-2019 | Hantavirus | Case report

Analysis of misdiagnosed cases of hemorrhagic fever with renal syndrome in children: two cases and literature review

Authors: Li Zhang, Qing-shan Ma, Yan Zhang, Bai-chao Sun, Leng-yue Zhao

Published in: BMC Nephrology | Issue 1/2019

Login to get access

Abstract

Background

Hemorrhagic fever with renal syndrome (HFRS) is an acute disease caused by hantavirus infection and is clinically characterized by fever, various hemorrhagic manifestations and transient renal and hepatic dysfunctions. Although various cases of HFRS have been reported, cases in children have rarely been described. Herein, we report two atypical cases of HFRS in children without distinctive manifestations and typical disease clinically progresses.

Case presentation

Patient 1 was a 11-year-old girl who attended our clinic for fever accompanying with acute renal failure, proteinuria and decreased level of complement 3 (C3) and thrombocytopenia without any hemorrhagic manifestations, acute glomerulonephritis was suspected first, especially lupus nephritis. Patient 2 was misdiagnosed as encephalitis at local hospital because of fever and headache for 4 days. With elevated liver transaminases, proteinuria and normal cerebrospinal fluid examination, HFRS was taken into consideration. Both of the two cases were supported and confirmed by serological test for Hantavirus.

Conclusions

Clinical manifestations of HFRS in children often presented atypically and were milder than adults. Febrile disease accompanying with thrombocytopenia may lead to the suspected diagnosis of HFRS.
Literature
1.
go back to reference Ferrés M, Vial P. Hantavirus infection in children [J]. Curr Opin Pediatr. 2004;16(1):70–5.CrossRef Ferrés M, Vial P. Hantavirus infection in children [J]. Curr Opin Pediatr. 2004;16(1):70–5.CrossRef
2.
go back to reference Piechotowski I, Brockmann SO, Schwarz C, Winter CH, Ranft U, Pfaff G. Emergence of hantavirus in South Germany: rodents, climate and human infections. Parasitol Res. 2008;103:S131–7.CrossRef Piechotowski I, Brockmann SO, Schwarz C, Winter CH, Ranft U, Pfaff G. Emergence of hantavirus in South Germany: rodents, climate and human infections. Parasitol Res. 2008;103:S131–7.CrossRef
4.
go back to reference Park Y. Epidemiologic study on changes in occurrence of hemorrhagic fever with renal syndrome in Republic of Korea for 17 years according to age group: 2001–2017[J]. BMC Infect Dis. 2019;19(1):153.CrossRef Park Y. Epidemiologic study on changes in occurrence of hemorrhagic fever with renal syndrome in Republic of Korea for 17 years according to age group: 2001–2017[J]. BMC Infect Dis. 2019;19(1):153.CrossRef
5.
go back to reference Zhao Q, Yang X, Liu H, et al. Effects of climate factors on hemorrhagic fever with renal syndrome in Changchun, 2013 to 2017[J]. Medicine. 2019;98(9):e14640.CrossRef Zhao Q, Yang X, Liu H, et al. Effects of climate factors on hemorrhagic fever with renal syndrome in Changchun, 2013 to 2017[J]. Medicine. 2019;98(9):e14640.CrossRef
6.
go back to reference Kruger DH. Tadeu Moraes Figueiredo L, song J-W, Klempa B. hantaviruses—globally emerging pathogens. J Clin Virol. 2015;64:128–36.CrossRef Kruger DH. Tadeu Moraes Figueiredo L, song J-W, Klempa B. hantaviruses—globally emerging pathogens. J Clin Virol. 2015;64:128–36.CrossRef
7.
go back to reference Huttunen NP, Mäkelä S, Pokka T, et al. Systematic literature review of symptoms, signs and severity of serologically confirmed nephropathia epidemica in paediatric and adult patients [J]. Scand J Infect Dis. 2011;43(6–7):6. Huttunen NP, Mäkelä S, Pokka T, et al. Systematic literature review of symptoms, signs and severity of serologically confirmed nephropathia epidemica in paediatric and adult patients [J]. Scand J Infect Dis. 2011;43(6–7):6.
8.
go back to reference Zhang WY, Fang LQ, Jiang JF, Hui FM, Glass GE, Yan L, et al. Predicting the risk of hantavirus infection in Beijing, People's Republic of China. Am J Trop Med Hyg. 2009;80(4):678–83.CrossRef Zhang WY, Fang LQ, Jiang JF, Hui FM, Glass GE, Yan L, et al. Predicting the risk of hantavirus infection in Beijing, People's Republic of China. Am J Trop Med Hyg. 2009;80(4):678–83.CrossRef
10.
go back to reference Dzagurova TK, Tkachenko EA, Ishmukhametov AA, et al. Severe hantavirus disease in children [J]. J Clin Virol. 2018;101:66–8.CrossRef Dzagurova TK, Tkachenko EA, Ishmukhametov AA, et al. Severe hantavirus disease in children [J]. J Clin Virol. 2018;101:66–8.CrossRef
11.
go back to reference Walter M, Udo B, Martin Z, et al. Hantavirus infection. J Am Soc Nephrol. 2005;16:3669–79.CrossRef Walter M, Udo B, Martin Z, et al. Hantavirus infection. J Am Soc Nephrol. 2005;16:3669–79.CrossRef
12.
go back to reference Fidan K, Polat M, Isiyel E, et al. An adolescent boy with acute kidney injury and fever. Hemorrhagic fever with renal syndrome (HFRS).[J]. Pediatr Nephrol. 2013;28(11):2115–6.CrossRef Fidan K, Polat M, Isiyel E, et al. An adolescent boy with acute kidney injury and fever. Hemorrhagic fever with renal syndrome (HFRS).[J]. Pediatr Nephrol. 2013;28(11):2115–6.CrossRef
13.
go back to reference Yoo KH, Choi Y. Haemorrhagic fever with renal syndrome in Korean children. Korean Society of Pediatric Nephrology.[J]. Pediatr Nephrol. 1994;8(5):540–4.CrossRef Yoo KH, Choi Y. Haemorrhagic fever with renal syndrome in Korean children. Korean Society of Pediatric Nephrology.[J]. Pediatr Nephrol. 1994;8(5):540–4.CrossRef
14.
go back to reference Vaheri A, et al. Hantavirus infections in Europe and their impact on public health. Rev Med Virol. 2013;23:35–49.CrossRef Vaheri A, et al. Hantavirus infections in Europe and their impact on public health. Rev Med Virol. 2013;23:35–49.CrossRef
15.
go back to reference Rista E, Pilaca A, Akshija I, et al. Hemorrhagic fever with renal syndrome in Albania. Focus on predictors of acute kidney injury in HFRS [J]. Journal of clinical virology the official publication of the Pan American Society for Clinical. Virology. 2017;91:25. Rista E, Pilaca A, Akshija I, et al. Hemorrhagic fever with renal syndrome in Albania. Focus on predictors of acute kidney injury in HFRS [J]. Journal of clinical virology the official publication of the Pan American Society for Clinical. Virology. 2017;91:25.
16.
go back to reference Jiang H, Zheng X, Wang L, et al. Hantavirus infection: a global zoonotic challenge [J]. Virol Sin. 2017;32(1):1–12.CrossRef Jiang H, Zheng X, Wang L, et al. Hantavirus infection: a global zoonotic challenge [J]. Virol Sin. 2017;32(1):1–12.CrossRef
17.
go back to reference Xiao H, Tian HY, Gao LD, et al. Animal reservoir, natural and socioeconomic variations and the transmission of hemorrhagic fever with renal syndrome in Chenzhou, China, 2006–2010[J]. PLoS Negl Trop Dis. 2014;8(1):e2615.CrossRef Xiao H, Tian HY, Gao LD, et al. Animal reservoir, natural and socioeconomic variations and the transmission of hemorrhagic fever with renal syndrome in Chenzhou, China, 2006–2010[J]. PLoS Negl Trop Dis. 2014;8(1):e2615.CrossRef
18.
go back to reference Echterdiek F, Kitterer D, Alscher MD, et al. Clinical course of hantavirus-induced nephropathia epidemica in children compared to adults in Germany—analysis of 317 patients[J]. Pediatr Nephrol. 2019;34(7):1247–52. Echterdiek F, Kitterer D, Alscher MD, et al. Clinical course of hantavirus-induced nephropathia epidemica in children compared to adults in Germany—analysis of 317 patients[J]. Pediatr Nephrol. 2019;34(7):1247–52.
19.
go back to reference Navarrete M, Hott M, Caroca J, et al. Correlation between clinical and laboratory criteria of suspected hantavirus cases and the results of the reference diagnostic technique. Rev Chil Infectol. 2016;33(3):275–28.CrossRef Navarrete M, Hott M, Caroca J, et al. Correlation between clinical and laboratory criteria of suspected hantavirus cases and the results of the reference diagnostic technique. Rev Chil Infectol. 2016;33(3):275–28.CrossRef
20.
go back to reference Wang M, Wang J, Wang T, Li J, Hui L, Ha X. Thrombocytopenia as a predictor of severe acute kidney injury in patients with Hantaan virus infections. PLoS One. 2013;8(1):e53236.CrossRef Wang M, Wang J, Wang T, Li J, Hui L, Ha X. Thrombocytopenia as a predictor of severe acute kidney injury in patients with Hantaan virus infections. PLoS One. 2013;8(1):e53236.CrossRef
21.
go back to reference Rasche FM, Uhel B, Kruger DH, Karges W, Czock D, Hampl W, Keller F, Meisel H, von Muller L. Thrombocytopenia and acute renal failure in Puumala hantavirus infections. Emerg Infect Dis. 2004;10(1):1420–5.CrossRef Rasche FM, Uhel B, Kruger DH, Karges W, Czock D, Hampl W, Keller F, Meisel H, von Muller L. Thrombocytopenia and acute renal failure in Puumala hantavirus infections. Emerg Infect Dis. 2004;10(1):1420–5.CrossRef
23.
go back to reference Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease.[J]. Clin Microbiol Rev. 2010;23(2):412–41.CrossRef Jonsson CB, Figueiredo LT, Vapalahti O. A global perspective on hantavirus ecology, epidemiology, and disease.[J]. Clin Microbiol Rev. 2010;23(2):412–41.CrossRef
24.
go back to reference Easterbrook JD, Klein SL. Immunological mechanisms mediating hantavirus persistence in rodent reservoirs. PLoS Pathog. 2008;4:e1000172.CrossRef Easterbrook JD, Klein SL. Immunological mechanisms mediating hantavirus persistence in rodent reservoirs. PLoS Pathog. 2008;4:e1000172.CrossRef
25.
go back to reference Gavrilovskaya IN, Gorbunova EE, Mackow NA, Mackow ER. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J Virol. 2008;82:5797–806.CrossRef Gavrilovskaya IN, Gorbunova EE, Mackow NA, Mackow ER. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J Virol. 2008;82:5797–806.CrossRef
26.
go back to reference Huggins JW, Hsiang CM, Cosgriff TM, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome [J]. J Infect Dis. 1991;164(6):1119–27.CrossRef Huggins JW, Hsiang CM, Cosgriff TM, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome [J]. J Infect Dis. 1991;164(6):1119–27.CrossRef
27.
go back to reference Malinin OV, Platonov AE. Insufficient efficacy and safety of intravenous ribavirin in treatment of haemorrhagic fever with renal syndrome caused by Puumala virus [J]. Infectious Diseases. 2017;49(7):514–20.CrossRef Malinin OV, Platonov AE. Insufficient efficacy and safety of intravenous ribavirin in treatment of haemorrhagic fever with renal syndrome caused by Puumala virus [J]. Infectious Diseases. 2017;49(7):514–20.CrossRef
28.
go back to reference Brocato RL, Hooper JW. Progress on the prevention and treatment of hantavirus disease. Viruses. 2019;11(7):610.CrossRef Brocato RL, Hooper JW. Progress on the prevention and treatment of hantavirus disease. Viruses. 2019;11(7):610.CrossRef
Metadata
Title
Analysis of misdiagnosed cases of hemorrhagic fever with renal syndrome in children: two cases and literature review
Authors
Li Zhang
Qing-shan Ma
Yan Zhang
Bai-chao Sun
Leng-yue Zhao
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2019
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-019-1562-0

Other articles of this Issue 1/2019

BMC Nephrology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.